menu
    • menu

    Company profile for Regencell Bioscience

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are an early-stage bioscience company that focuses on research, development and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”), Autism Spectrum Disorder (“ASD”) in infectious diseases such as COVID-19. Our goal is to improve the lives of ADHD, ASD and COVID patients, their families and caregivers and become a mar...
    We are an early-stage bioscience company that focuses on research, development and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”), Autism Spectrum Disorder (“ASD”) in infectious diseases such as COVID-19. Our goal is to improve the lives of ADHD, ASD and COVID patients, their families and caregivers and become a market leader for the best TCM treatment globally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Regencell BioscienceHongKong Flag
    Country
    Country
    Hong Kong
    Address
    Address
    9/F Chinachem Leighton Plaza 29 Leighton Road Causeway Bay
    Telephone
    Telephone
    +852 2155 0823
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regencellbioscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/regencell-bioscience-holdings-limited/?originalSubdomain=hk
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Regencell Bioscience Limited Announces Forward Stock Split
    Regencell Bioscience Limited Announces Forward Stock Split

    17 Jun 2025

    // PRESS RELEASE

    https://regencellbioscience.com/regencell-bioscience-holdings-limited-announces-the-forward-stock-split-is-effected/

    PRESS RELEASE
    17 Jun 2025
    Share Share
    Regencell Standardized Formulae Are Shown to Reduce ADHD & ASD Symptoms
    Regencell Standardized Formulae Are Shown to Reduce ADHD & ASD Symptoms

    12 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220912005506/en

    BUSINESSWIRE
    12 Sep 2022
    Share Share
    Regencell: Announces First Half 2022 Management Financial Results - Form 6-K
    Regencell: Announces First Half 2022 Management Financial Results - Form 6-K

    02 Jun 2022

    // MARKETSCREENER

    https://www.marketscreener.com/quote/stock/REGENCELL-BIOSCIENCE-HOLD-124803353/news/Regencell-Bioscience-Announces-First-Half-2022-Management-Financial-Results-Form-6-K-40625825/

    MARKETSCREENER
    02 Jun 2022
    Share Share
    Regencell Bioscience Announces Additional EARTH Efficacy Trial Results
    Regencell Bioscience Announces Additional EARTH Efficacy Trial Results

    18 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220518005682/en

    BUSINESSWIRE
    18 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search